Facial Injectable Market Size To Reach $22.1 Billion By 2033

Facial Injectable Market Growth & Trends

The global facial injectable market size is expected to reach USD 22.1 billion by 2033, registering a CAGR of 8.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

 Request a free sample copy or view report summary: Facial Injectable Market Report

Facial Injectable Market Report Highlights

• Based on product, the botulinum toxin (Botox) segment held the largest market share of 47.3% in 2025. It is one of the most popularly used minimally invasive procedures.

• Based on application, the wrinkle correction segment dominated the market, accounting for the largest revenue share in 2025. The growth is primarily driven by the high global prevalence of facial aging signs, such as fine lines, crow’s feet, and forehead wrinkles, which remain the most common aesthetic concerns among adults.

• Based on end use, the aesthetic surgery centers segment dominated the market and accounted for the largest revenue share 43.02 in 2025. The growth is primarily due to the high concentration of skilled practitioners, advanced technologies, and specialized treatment offerings available at these facilities.

• North America dominated the market with a revenue share of 38.9% in 2025 owing to the easy availability of the products and the presence of a large number of skilled surgeons.

• The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market.

Facial Injectable Market Segmentation

Grand View Research has segmented the global facial injectable market report based on product, application, end use and region:

Facial Injectable Product Outlook (Revenue, USD Million, 2021 - 2033)

• Collagen and PMMA Microspheres

• Hyaluronic Acid

  • Monophasic

  • Biphasic

• Calcium Hydroxylapatite (CaHA)

• PLLA

• PCL

• PN/PDRN

• Botulinum Toxin (Botox)

• Exosome

Facial Injectable Application Outlook (Revenue, USD Million, 2021 - 2033)

• Wrinkle Correction

• Lip Augmentation

• Facial Contouring

• Scar Treatment

• Volume Loss Restoration

• Others

Facial Injectable End Use Outlook (Revenue, USD Million, 2021 - 2033)

• MedSpas

• Aesthetic Surgery Centers

• Hospitals

• Others

Facial Injectable Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Russia

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

  • Vietnam

  • Philippines

  • Singapore

  • Malaysia

  • Taiwan

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • Kuwait

  • UAE

List of Key Players in Facial Injectable Market

• Ipsen

• Abbvie

• Medytox Inc.

• Merz GmbH and Co. KGaA

• Revance Therapeutics, Inc.

• Galderma

• Sinclair Pharma